On supercomputers and life sciences, listening to Treasury naysayers risks letting work and political capital slip away ...

At the Capability Leaders Forum, marketers from AstraZeneca, Reckitt and Trainline discussed the potential of genAI to ...

Manchester’s health and life sciences sector is thriving, but as experts at Insider’s roundtable discussed, unlocking its full potential will require greater ...

One of the newest engineering marvels to come out of Kendall Square will be buried up to 105 feet underground where no one ...

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

AstraZeneca has reinforced its commitment to advancing cancer care through early detection, innovative treatments, and equitable healthcare access in recognition of World Cancer Day 2025 under the ...

The UK’s science minister, Chris Bryant, has described AstraZeneca’s decision to scrap plans for a £450m expansion of its ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult ...

The Cambridge, England-based and Tokyo-based pharmaceutical companies said the US Food & Drug Administration approved Enhertu for the treatment of adult patients with unresectable or metastatic ...